United States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

Table of Contents

United States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products, Executive SummaryIntroduction to the U.S. Hemostats; Tissue Sealants and Adhesives; and Adhesion Prevention Products MarketObjectives and PurposeReport Scope and SegmentationReport Structure Summary of Major FindingsTotal Revenue and Revenue Growth RatesPercent of Revenues by Product TypeAnalysis by Major SegmentCompetitive AnalysisUnited States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products, Market Engineering Research MethodologyFrost & Sullivan's 12-Step Market Engineering Research MethodologyFrost & Sullivan's 12-Step Market Engineering Research MethodologyFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryFrost & Sullivan's Market Engineering Forecasting Methodology for the Healthcare IndustryIndustry Specific Forecast ModelIndustry Specific Forecast ModelProcedure-Based ModelProduct-Based ForecastRole of Secondary and Primary ResearchResearch SourcesSecondary SourcesPrimary ResearchPresentation of Market Engineering Measurements; Definition and their Strategic SignificancePresentation of Market Engineering Measurements; Definition and their Strategic SignificanceGlossary of TermsList of DefinitionsList of AcronymsUnited States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products, Industry ChallengesIdentification of ChallengesIdentification of ChallengesStringent FDA Requirements Create Uncertain Return on InvestmentCost Containment Pressures Push Down PricesLack of Education and Training Slows Product AcceptanceExisting International Products Increase the Threat of Foreign Competitors Buyer Consolidation Prevents Introduction of New ProductsShortage of Raw Materials and Limited Manufacturing Capabilities Obstruct Market PenetrationLack of Reimbursement Hinder the Introduction of New TechnologiesInsufficient Sales and Marketing Capabilities Squeeze Out Small ManufacturersPhysician Reluctance to Switch to New Technologies Hampers Market PenetrationHigh Costs of Research; Development and Marketing Make It Difficult to Commercialize All Potential ProductsMarket Engineering Research for the U.S. Topical Hemostat MarketTotal Market AnalysisOverviewMarket DriversMarket RestraintsMarket Engineering Revenue Forecasts (1995-2005)Competitive AnalysisMarket Engineering Analysis of the U.S. Collagen-Based Topical Hemostat MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisProduct AnalysisMarket Engineering Analysisof the U.S. Oxidized Regenerated Cellulose-Based Topical Hemostat MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisProduct AnalysisMarket Engineering Analysis of the U.S. Gelatin-Based Topical Hemostat MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisProduct AnalysisMarket Engineering Analysis of the Thrombin-Based Topical Hemostat MarketMarket Overview and DefinitionsMarket Engineering Research Measurement SystemMarket Engineering Unit and Revenue Forecasts (1995-2005)Competitive AnalysisProduct AnalysisMarket Engineering Research for the U.S. Tissue Sealants Market Market Overview and DefinitionsOverviewDefinitionsScopeHistoryDevice ClassificationProduct AnalysisProduct TypeProducts on the MarketProducts in Clinical TrialsProducts in DevelopmentApplicationsApplicationsSpecialtiesDelivery DevicesMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversMore Effective Surgeries Reduce Hospital CostsProblems with Blood Bank Tissue Sealants Shift Attention to Commercial SealantsOngoing R&D Propels New Technologies and IndicationsMarket RestraintsMarket RestraintsRisk of Disease Transmission and Toxic Reactions Insufficient Promotion and Education Poor Quality and Design of Delivery Devices Limited Manufacturing Capabilities and Access to Raw Materials Restricts Product Supply to MarketsMarket Engineering Unit and Revenue Forecasts (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesRevenue Trends by Procedure TypeRevenue Trends by Product TypeCompetitive AnalysisCompetitive StructureCompetitive FactorsMarket Share AnalysisMarket Share Winners and WhyMarket Engineering Research for the Blood Bank Tissue Sealant MarketMarket Overview and DefinitionsOverviewDefinitionScopeHistoryApplications/UseEquipmentBlood banks versus Commercial Tissue SealantsNumber of Hospitals Using Blood bank Tissue SealantsUnit DefinitionMarket Engineering Unit and Revenue Forecasts (1995-2005)Pricing AnalysisUnit ShipmentsRevenuesMarket Engineering Research for the U.S. Cyanoacrylate-Based Tissue Adhesives MarketMarket Overview and DefinitionsOverviewDefinitionScope/SegmentationHistoryTypes of DevicesDevice ClassificationUseUnit DefinitionMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket DriversMarket DriversCost and Time of Treatment versus Sutures Is Considerably LessEliminating the Need for Sutures Reduces Patient AnxietyTrend Toward Minimally Invasive Surgeries Encourages UseDevelopment of Products for Internal Applications Adds New Dimension to MarketEntrance of New Participants to the U.S. Market Expected to Spur GrowthMarket RestraintsMarket RestraintsEstablished Technology Restricts Market GrowthSole Distributor Also Dominates the Suture and Staple MarketsOutdated Studies Finding That Some Forms of Cyanoacrylates Are Toxic Expected to Counter Market PenetrationMarket Engineering Unit and Revenue Forecasts (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesCompetitive AnalysisCompetitive StructureCompetitive FactorsMarket Share AnalysisMarket Share Winners and WhyProduct AnalysisProduct on the MarketProducts in Clinical TrialsMarket Engineering Research for the U.S. Adhesion Prevention Products MarketTotal Adhesion PreventionProducts Market AnalysisMarket Overview and DefinitionsMarket DriversMarket DriversExpanding Indications for Adhesion Prevention Products Increases Market SizeIntroduction of New Products Are Expected to Broaden Market BaseNew Applications from theDevelopment of Gel and Liquid TechnologiesAging Population Increases the Number of SurgeriesMarket RestraintsMarket RestraintsLack of Long-Term Outcome Data Slows Market AcceptancePotential Application of Products fora Wide Range of Procedures Presents Distribution ChallengesTrend Toward Minimally Invasive Procedures Reduces the Application of Barrier FilmsFailure of Products to Attain Marketing Approval in the U.S. Generates SkepticismMarket Engineering Research Measurement SystemMarket Engineering Research Measurement SystemMarket Engineering Revenue Forecasts (1995-2005)Total RevenuesRevenue Trends by ProcedureCompetitive AnalysisMarket Engineering Unit and Revenue Forecasts—Abdominal Procedures (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesCompetitive AnalysisProduct AnalysisMarket Engineering Unit and Revenue Forecasts—Pelvic/Gynecological Procedures (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesCompetitive AnalysisProduct AnalysisMarket Engineering Unit and Revenue Forecasts—Spinal Procedures (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesCompetitive AnalysisProduct AnalysisMarket Engineering Unit and Revenue Forecasts—Cardiac Procedures (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesProduct AnalysisMarket Engineering Unit and Revenue Forecasts—Tendon and Peripheral Nerve Procedures (1995-2005)ProceduresPricing AnalysisUnit ShipmentsRevenuesProduct AnalysisUnited States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products, Market Engineering StrategyWhat Is Market Engineering Strategy?What Is Market Engineering Strategy?Market Engineering Strategic RecommendationsMarket Engineering Strategic RecommendationsDevelop Strategic Alliances and Partnerships to Leverage Limited ResourcesEstablish Competitive Advantages Through Vertical Integration Ensure Reimbursement Through AwarenessDevelop Physician and PatientEducation Programs to Increase Market PenetrationUnited States Markets for Hemostats; Tissue Sealant and Adhesives; and Adhesion Prevention Products, Market Engineering AwardsFrost & Sullivan's 1998 Market Engineering AwardFrost & Sullivan's 1998 Market Engineering AwardThe 1998 Market Engineering Product Innovation Award—American Red CrossThe 1998 Market Engineering Market Penetration Strategy Award—Gliatech Inc.




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.